Parallax Volatility Advisers
GH icon

Parallax Volatility Advisers’s Guardant Health GH Stock Holding History

Parallax Volatility Advisers’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40
Closed -$1.73K – 1775
2024
Q4 		$1.22K Buy
+40
New +$1.13K ﹤0.01% 1902
2022
Q4 		– Sell
-51,226
Closed -$2.76M – 3024
2022
Q3 		$2.76M Buy
+51,226
New +$2.63M ﹤0.01% 1270
2020
Q2 		– Sell
-786
Closed -$55K – 2757
2020
Q1 		$55K Buy
786
+325
+70% +$24.9K ﹤0.01% 2241
2019
Q4 		$36K Buy
+461
New +$33.2K ﹤0.01% 2255

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Parallax Volatility Advisers's GH Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Guardant Health (GH) in Q1 2025, closing a stake of 40 shares — an estimated $1.73K sold.

Parallax Volatility Advisers first reported a position in GH in Q4 2019 and held it in 4 quarters. The position peaked at $2.76M in Q3 2022. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 40 Guardant Health shares in Q1 2025, an estimated $1.73K.
  • Parallax Volatility Advisers first reported a position in Guardant Health in Q4 2019 and held it in 4 quarters.
  • Parallax Volatility Advisers's Guardant Health position peaked at $2.76M in Q3 2022.
  • 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.